California Nanotechnologies (CNO) AI Stock Analysis

• Market Cap: C$18.04M
• Dividend Yield: N/A
• Average Volume (3M): 35.75K
• Price to Earnings (P/E): ―
• Beta (1Y): 3.95
• Revenue Growth: -15.84%
• EPS Growth: -375.96%
• Country: CA
• Employees: N/A
• Sector: General
• Sector Strength: N/A
• Industry: Chemicals - Specialty
• EPS (TTM): 0.00
• Shares Outstanding: 50,097,970
• 10 Day Avg. Volume: 35,432
• 30 Day Avg. Volume: 35,752
• PEG Ratio: 0.94
• Price to Book (P/B): 8.69
• Price to Sales (P/S): 3.23
• P/FCF Ratio: 25.26
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: C$0.33 ▼(-2.06% Downside)

The score is held down primarily by weakening financial performance (TTM revenue decline and a return to sizable losses) and a weak price trend (below key moving averages with negative MACD). Support comes from improved balance-sheet footing and positive operating cash flow, but valuation support is limited due to negative earnings and no dividend data.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a healthy expansion trajectory, suggesting strong demand for CNO's nanotechnology solutions across its key sectors.

Cash Flow Generation

Strong cash flow generation provides a solid foundation for future financial stability, enabling CNO to invest in R&D and strategic partnerships.

Improved Equity Position

Improved equity positions suggest enhanced financial stability, reducing risk and potentially lowering the cost of capital for future growth.

Negative Factors

Profitability Challenges

Weak profitability metrics highlight challenges in converting revenue growth into net income, which could impact long-term financial sustainability.

High Leverage

High leverage poses a risk to financial stability, potentially limiting CNO's ability to finance new projects or weather economic downturns.

Volatility in Funding Strategies

Volatility in funding strategies could lead to inconsistent capital availability, affecting CNO's ability to maintain steady growth and operational efficiency.

California Nanotechnologies Business Overview & Revenue Model

Company Description

California Nanotechnologies Corp. engages in the research, development, and production of nanocrystalline materials through grain size reduction. The company provides spark plasma/ field assisted sintering (SPS/FAST); hot pressing; sintering; diffusion bonding; hot isostatic pressing; vacuum pressureless sintering; cryogenic milling, inert gas milling, planetary ball milling, and pulverizing; and material development and testing services, including mechanical alloying, composites/non-composites, mechanical testing, sample fabrication, prototyping, scanning electron microscopy analysis, and particle size analysis. It also offers SPS starter accessory kits, SPS graphite tooling, SPS systems, tungsten carbide tooling, SPS graphite crucibles, carbon graphite foil/paper, carbon felt and yarn, and quartz glass windows; and Engemini, an SPS/FAST modeling software. It serves aerospace, defense, automotive, medical, and sports and recreation industries. The company is headquartered in Cerritos, California.

How the Company Makes Money

California Nanotechnologies generates revenue through multiple streams, including the sale of proprietary nanomaterials and coatings to industries such as aerospace, electronics, and defense. The company also engages in research and development contracts with government and private sector clients, providing tailored solutions that meet specific industry needs. Additionally, CNO benefits from strategic partnerships with major corporations and research institutions, which facilitate access to new markets and collaborative projects. Licensing agreements for its technologies further contribute to its earnings, allowing other businesses to incorporate CNO's innovations into their own products and processes.

California Nanotechnologies Financial Statement Overview

Summary

California Nanotechnologies shows promising revenue growth and improving equity positions, but profitability challenges and high leverage present potential risks. Strong cash flow generation provides a solid foundation for future financial stability.

Income Statement

The company has shown strong revenue growth, with significant increases in total revenue each year, indicating a healthy expansion trajectory. However, profitability metrics such as net profit margin are weak due to a negative net income in the latest period, which impacts the overall score. Gross profit margin is robust, reflecting efficient cost management, but the net loss in the TTM period is a concern.

Balance Sheet

The balance sheet reveals high leverage, with a substantial debt-to-equity ratio due to negative equity in previous years. The equity ratio has improved but remains low, showing risk in financial stability. The recent positive stockholders' equity is a positive sign, indicating improved financial health.

Cash Flow

Cash flow performance is strong, with positive free cash flow growth and a high operating cash flow to net income ratio, which indicates good cash generation relative to income. However, fluctuations in financing cash flow might indicate volatility in funding strategies.

Breakdown	TTM	Dec 2024	Dec 2024	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.45M	3.34M	6.22M	1.82M	1.36M	1.10M
Gross Profit	2.58M	2.33M	4.59M	669.57K	514.32K	523.36K
EBITDA	15.37K	753.02K	780.97K	337.91K	314.81K	141.12K
Net Income	-939.65K	381.68K	-158.33K	79.76K	200.60K	-74.36K
Balance Sheet
Total Assets	6.00M	2.36M	5.50M	1.41M	1.22M	864.54K
Cash, Cash Equivalents and Short-Term Investments	327.02K	841.35K	533.85K	294.13K	65.11K	56.31K
Total Debt	1.47M	1.21M	1.62M	1.94M	2.15M	2.31M
Total Liabilities	2.74M	2.21M	3.19M	2.70M	2.58M	2.47M
Stockholders Equity	3.25M	145.97K	2.32M	-1.29M	-1.36M	-1.61M
Cash Flow
Free Cash Flow	328.92K	89.98K	797.00K	604.26K	45.29K	180.62K
Operating Cash Flow	2.09M	104.28K	2.92M	717.01K	54.97K	180.62K
Investing Cash Flow	-1.75M	-14.30K	-2.11M	-112.75K	―	0.00
Financing Cash Flow	-728.09K	535.33K	-1.12M	-387.83K	―	-149.61K

California Nanotechnologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.34
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CNO, the sentiment is Positive. The current price of 0.34 is above the 20-day moving average (MA) of 0.34, below the 50-day MA of 0.35, and below the 200-day MA of 0.46, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 55.68 is Neutral, neither overbought nor oversold. The STOCH value of 64.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CNO.

California Nanotechnologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
BOS	53 Neutral	C$125.70M	-24.60	-2.95%	3.12%	5.06%	93.02%
CNO	47 Neutral	C$18.04M	-12.54	-61.05%	―	-15.84%	-375.96%
GMG	46 Neutral	C$408.67M	-42.79	-92.59%	―	6.29%	-3.71%
SURE	46 Neutral	C$8.37M	-318.18	―	―	―	91.27%
IZ	45 Neutral	C$424.07K	100.00	―	―	109.13%	―
NANO	42 Neutral	C$131.69M	-8.82	-64.59%	―	―	56.03%

California Nanotechnologies Corporate Events

California Nanotechnologies Expands SPS Footprint with Dr. Fritsch Distribution and R&D Partnership

California Nanotechnologies has entered into a strategic agreement with Germany’s Dr. Fritsch Sondermaschinen GmbH to act as the North American distributor and R&D services partner for Dr. Fritsch’s larger-scale Spark Plasma Sintering equipment, including aftermarket support. Under the deal, Cal Nano will provide developmental trials, pilot-scale validation and material evaluation services for Dr. Fritsch customers, an arrangement aimed at expanding both firms’ reach among North American industrial and research clients, particularly in defense and energy sectors that face export restrictions. The partnership complements Cal Nano’s existing relationship with Japan’s SUGA Co., Ltd., broadening its SPS equipment portfolio without product overlap, and is expected to strengthen the company’s role in advancing Spark Plasma Sintering technologies. In parallel, Cal Nano will host its inaugural SPS/FAST Experts Workshop in March 2026 alongside TMS 2026 in San Diego, showcasing advanced sintering technologies and its large-scale SPS systems, further reinforcing its visibility and positioning in the advanced materials community.

The most recent analyst rating on (TSE:CNO) stock is a Hold with a C$0.36 price target. To see the full list of analyst forecasts on California Nanotechnologies stock, see the TSE:CNO Stock Forecast page.

California Nanotechnologies Secures Orders for Nuclear Reactor Components

California Nanotechnologies Corp. has secured two purchase orders worth approximately $196,250 from a U.S.-based company focused on advanced small modular nuclear reactors. These orders involve the production of boron-carbide reactor control rods for the client’s first demonstration reactor, highlighting Cal Nano’s role in the domestic nuclear supply chain. The company’s expertise in advanced materials and rapid production capabilities were key in securing this partnership. Additionally, Cal Nano will host its inaugural SPS/FAST Experts Workshop in March 2026, showcasing advanced sintering technologies and offering networking opportunities.

The most recent analyst rating on (TSE:CNO) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on California Nanotechnologies stock, see the TSE:CNO Stock Forecast page.

California Nanotechnologies Secures Key Orders for Nuclear Reactor Components

California Nanotechnologies Corp. has secured two purchase orders worth approximately $196,250 from a U.S.-based company for the production of boron-carbide reactor control rods for small modular nuclear reactors. This development highlights Cal Nano’s capability to meet accelerated timelines and specifications, reinforcing its position as a key player in the nuclear supply chain. The orders will be fulfilled at their Santa Ana facility using advanced sintering technologies, and the company is also set to host an SPS/FAST Experts Workshop in 2026, showcasing their expertise and facilities.

The most recent analyst rating on (TSE:CNO) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on California Nanotechnologies stock, see the TSE:CNO Stock Forecast page.